INDmoney
Lineage Cell Therapeutics Inc Stock Performance
as on February 21, 2026 at 7:59 am IST
Day's Low
Day's High
$1.73$1.85
3.89%
Downside
2.78%
Upside
52 Week's Low
52 Week's High
$0.37$2.0979.72%
Downside
16.11%
Upside
Lineage Cell Therapeutics Inc share price movements today
- Previous Close
- $1.78
- Open
- $1.73
- Volume
- 1.2M
- Day's Low - High
- $1.73 - $1.85
- 52 Week Low - High
- $0.37 - $2.09
Lineage Cell Therapeutics Inc Historical Returns
- 1 Month Return
- + 9.04 %
- 3 Month Return
- + 4.02 %
- 1 Year Return
- + 167.75 %
- 3 Year Return
- + 43.65 %
- 5 Year Return
- -35.13 %
Lineage Cell Therapeutics Inc Stock Fundamentals & Key Indicators
Check Lineage Cell Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$410.0M
EPS (TTM)
-0.2883
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.85
Industry PE ratio
0PEG Ratio
0EBITDA
-19.7M
Revenue (TTM)
10.8M
Profit Margin
0.00%
Return On Equity TTM
-157.75%
Lineage Cell Therapeutics Inc Stock Valuation
Track how Lineage Cell Therapeutics Inc P/E has moved over time to understand its valuation trends.
Lineage Cell Therapeutics Inc in the last 5 years
Lowest (-32.34x)
June 30, 2021
Industry (0.00x)
February 21, 2026
Today (-6.85x)
February 21, 2026
Highest (-3.30x)
June 30, 2025
Today’s Price to Earnings Ratio: -6.85x
Lineage Cell Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lineage Cell Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $410.0M | -35.13% | -6.85 | 0.00% | |
| BUY | $119.2B | 130.36% | 30.67 | 32.94% | |
| NA | $39.2B | NA | 668.83 | 1.38% | |
| BUY | $45.0B | 116.81% | 145.03 | 8.45% | |
| BUY | $82.7B | 65.76% | 18.87 | 31.41% |
Stock Returns calculator for Lineage Cell Therapeutics Inc Stock including INR - Dollar returns
The Lineage Cell Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lineage Cell Therapeutics Inc investment value today
Current value as on today
₹2,69,769
Returns
₹1,69,769
(+169.77%)
Returns from Lineage Cell Therapeutics Inc Stock
₹1,64,706 (+164.71%)
Dollar Returns*
₹5,064 (+5.06%)
Analyst Recommendation on Lineage Cell Therapeutics Inc Stock
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Lineage Cell Therapeutics Inc. Average target price of $4.17
Lineage Cell Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Lineage Cell Therapeutics Inc.
What analysts predicted
56.83%UPSIDE
Target Price
$4.17
Current Price
$1.8
Analyzed by
12 Analysts
Target
$4.17
Lineage Cell Therapeutics Inc target price $4.17, a slight upside of 56.83% compared to current price of $1.8. According to 12 analysts rating.
Lineage Cell Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Lineage Cell Therapeutics Inc Stock has increased by 189% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:189% versus previous 30 day period
Lineage Cell Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Lineage Cell Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Lineage Cell Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Lineage Cell Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Lineage Cell Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, LCTX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, LCTX stock has moved up by 9.0%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -30.46M → -29.78M (in $), with an average increase of 2.3% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.50M → 3.68M (in $), with an average increase of 35.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.1% return, outperforming this stock by 14.4%
About Lineage Cell Therapeutics Inc
| Organisation | Lineage Cell Therapeutics Inc |
| Headquarters | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
| Industry | Health Technology |
| CEO | Mr. Brian M. Culley M.A., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Lineage Cell Therapeutics Inc
Name | Title |
|---|---|
Mr. Brian M. Culley M.A., M.B.A. | CEO, President & Director |
Ms. Ioana C. Hone | Director of Investor Relations |
Dr. Charlotte Hubbert Ph.D. | Vice President of Corporate Development |
Ms. Brandi L. Roberts CPA, M.B.A. | Consultant |
Ms. Alexandra Hernandez | Senior Director of Finance & Controller |
Ms. Jill Ann Howe | CFO & Principal Financial and Accounting Officer |
Mr. George A. Samuel III, J.D. | General Counsel & Company Secretary |
Dr. Rami Skaliter M.Sc., Ph.D. | Chief Executive Officer of Cell Cure Neurosciences |
Dr. Harold D. Waitz | Vice President of Regulatory Affairs & Quality Control |
FAQs
What is Lineage Cell Therapeutics Inc share price today?
Lineage Cell Therapeutics Inc share price today is $1.8 as on at the close of the market. Lineage Cell Therapeutics Inc share today touched a day high of $1.85 and a low of $1.73.
What is the 52 week high and 52 week low for Lineage Cell Therapeutics Inc share?
Lineage Cell Therapeutics Inc share touched a 52 week high of $2.09 on and a 52 week low of $0.37 on . Lineage Cell Therapeutics Inc stock price today i.e. is closed at $1.8,which is 13.88% down from its 52 week high and 393.02% up from its 52 week low.
What is Lineage Cell Therapeutics Inc's market capitalisation today?
Lineage Cell Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Lineage Cell Therapeutics Inc Stock (LCTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Lineage Cell Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lineage Cell Therapeutics Inc Shares that will get you 0.8333 shares as per Lineage Cell Therapeutics Inc share price of $1.8 per share as on February 21, 2026 at 2:29 am IST.
What is the minimum amount required to buy Lineage Cell Therapeutics Inc Stock (LCTX) from India?
Indian investors can start investing in Lineage Cell Therapeutics Inc (LCTX) shares with as little as ₹90.973 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹909.73 in Lineage Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lineage Cell Therapeutics Inc share’s latest price of $1.8 as on February 21, 2026 at 2:29 am IST, you will get 5.5556 shares of Lineage Cell Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Lineage Cell Therapeutics Inc has given to Indian investors in the last 5 years?
Lineage Cell Therapeutics Inc stock has given -35.13% share price returns and 25.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?